Phosphodiesterase 9A controls nitric-oxide-independent cGMP and hypertrophic heart disease.

MLA

Lee, Dong I., et al. “Phosphodiesterase 9A Controls Nitric-Oxide-Independent CGMP and Hypertrophic Heart Disease.” Nature, vol. 519, no. 7544, Mar. 2015, pp. 472–76. EBSCOhost, https://doi.org/10.1038/nature14332.

APA

Lee, D. I., Zhu, G., Sasaki, T., Cho, G.-S., Hamdani, N., Holewinski, R., Jo, S.-H., Danner, T., Zhang, M., Rainer, P. P., Bedja, D., Kirk, J. A., Ranek, M. J., Dostmann, W. R., Kwon, C., Margulies, K. B., Van Eyk, J. E., Paulus, W. J., Takimoto, E., & Kass, D. A. (2015). Phosphodiesterase 9A controls nitric-oxide-independent cGMP and hypertrophic heart disease. Nature, 519(7544), 472–476. https://doi.org/10.1038/nature14332

Chicago

Lee, Dong I., Guangshuo Zhu, Takashi Sasaki, Gun-Sik Cho, Nazha Hamdani, Ronald Holewinski, Su-Hyun Jo, et al. 2015. “Phosphodiesterase 9A Controls Nitric-Oxide-Independent CGMP and Hypertrophic Heart Disease.” Nature 519 (7544): 472–76. doi:10.1038/nature14332.